Allergy Shot Effectiveness: Per-Injection vs Full-Course
No single allergy shot is independently effective — effectiveness is a function of the cumulative dose reaching and sustaining the maintenance level (Cox 2011 PP3). Build-up involves approximately 26–28 weekly injections; relief in the first 6 months is partial and unreliable. Most patients notice improvement between months 6–12, with maximum benefit in years 2–3. Cumulative-course Cochrane SMD is −0.73 (Calderón 2007, 51 RCTs). In real-world US data, 23.9% never return after their first injection (Tkacz 2021).
8 peer-reviewed sources
A single allergy shot is a building block, not a treatment. No individual injection is effective — the cumulative course over 3–5 years produces the Cochrane symptom SMD of −0.73. Most patients notice improvement at months 6–12 of treatment.
Key facts
A 2026 observational cohort of 2,897 patients on at-home sublingual immunotherapy reported clinically meaningful improvement rising from 28% at 12 months to 45% at 24 months, showing how benefit accrues with time on treatment rather than arriving early.
The essentials
When patients ask about allergy shot effectiveness, they sometimes ask about a single injection — whether that specific shot worked, or whether they should expect relief after a few shots. The honest answer is that no single shot is independently effective. A single injection is one building block in a gradual dose-escalation protocol, not a treatment.
Per-injection effectiveness depends on the vial matching the dominant sensitization — Curex at-home IgE testing with allergist review identifies the specific allergen target, avoiding the multi-allergen-mix dilution that reduces per-injection biological potency.
The build-up phase involves approximately 26–28 weekly injections of gradually increasing allergen extract concentration, from a starting dose far below symptom-triggering levels up to the maintenance dose (Cox L et al., JACI 2011;127[1 Suppl]:S1–S55, DOI 10.1016/j.jaci.2010.09.034). The Cox 2011 AAAAI/ACAAI/JCAAI Practice Parameter Third Update explicitly characterizes the build-up period as the phase when relief is partial and unreliable. This is by design — the purpose of build-up is to reach the maintenance dose safely, not to provide symptom control.
Each injection also carries a per-injection risk: local reactions (redness, swelling, itching) occur in approximately 16.3% of injections (Calabria CW et al., LOCAL study, JACI 2009;124:739–744); systemic reactions occur in approximately 0.1% of injection visits (Epstein TG et al., JACIP 2014;2:161–167). Most systemic reactions begin within 30 minutes of an injection (Cox 2011 PP3), which is why a prescribed epinephrine auto-injector should be confirmed on hand and why the Curex at-home program (curex.com/c/scit-v1) supervises the first injection from each new vial or concentration live in the Virtual Shot Room — making safe at-home self-administration possible for eligible patients. A large safety study of self-administered allergen immunotherapy (Schaffer et al., 2015) found that across 23,614 patients giving 2,021,600 injections, the systemic reaction rate was just 0.16% per patient with no fatalities — lower than the 3%–14% typically seen with office-based shots.
Most patients begin to notice clear improvement between months 6 and 12, as the maintenance dose is established. Walker SM et al. (JACI 2001;107:87–93, DOI 10.1067/mai.2001.112027) documented the grass SCIT improvement accruing across the first maintenance season. Maximum symptom and medication reductions accrue in years 2–3 (Durham SR et al., NEJM 1999;341:468–475, DOI 10.1056/NEJM199908123410702). Durable post-treatment remission requires a minimum of 3–4 completed years.
The cumulative-course effectiveness documented in the Cochrane literature is a symptom SMD of −0.73 and medication SMD of −0.57 (Calderón MA et al., Cochrane 2007, CD001936, DOI 10.1002/14651858.CD001936.pub2) — not the effectiveness of any single injection, but the cumulative biological effect of hundreds of injections over years.
Ready to skip the surprise bills?
At-home allergy shots (SCIT) are designed by board-certified allergists. See the listed SCIT plan rate in our pricing record and request a quote for eligibility, initiation and total care costs.
- MD-ledBoard-certified allergists
- QuoteTotal care estimate
- 50K+Patients treated
- HSA/FSAEligible
Treatment timeline — phase by phase
Effectiveness follows the treatment phase — each injection builds toward the cumulative therapeutic outcome, not toward immediate relief.
Escalating doses from far below symptom threshold up to maintenance dose. Cox 2011 PP3 explicitly characterizes this phase as producing partial and unreliable relief. Purpose is reaching the maintenance dose safely, not symptom control.
Stable dose at or near the maintenance level. Most patients notice improvement between months 6–12 of treatment. Maximum benefit accrues in years 2–3 (Durham 1999). Maintenance injections are common during maintenance.
Post-treatment remission ≥3 years documented by Durham SR et al. (NEJM 1999). Some long-term observational data describe benefit persisting 7–12+ years. Re-initiation is possible if relapse occurs.
See if Curex's at-home allergy shot program fits your allergies
Curex delivers personalized allergy shot treatment with a build-up schedule designed around your allergens.
See if you qualifyCurex allergy shot serum is compounded at a specialty pharmacy for each patient, and the FDA does not review compounded products for safety or efficacy.
Treatment options side by side
The per-injection time investment (clinic visit + observation, in the traditional model) must be multiplied by the number of injections required to reach effectiveness. The Curex at-home program now delivers the same SCIT serum as one weekly shot self-administered at home — removing the per-visit clinic trip and the per-visit dropout risk, while the first injection from each new vial or concentration stay supervised live in the Virtual Shot Room. Sublingual immunotherapy drops are a separate at-home modality some patients choose instead.
| Treatment | Efficacy | Duration | Cost (5yr) | Convenience | Safety |
|---|---|---|---|---|---|
SCIT (allergy shots) | |||||
SLIT drops (off-label) |
- Efficacy
- Duration
- Cost (5yr)
- Convenience
- Safety
- Efficacy
- Duration
- Cost (5yr)
- Convenience
- Safety
Curex now delivers the allergy shot itself at home: a personalized SCIT serum sterile-compounded to USP <797>, self-administered as one weekly shot, with pricing confirmed in a current program quote (curex.com/c/scit-v1). A prescribed epinephrine auto-injector is confirmed on hand before the first dose, the first injection from each new vial or concentration is supervised live in the Virtual Shot Room, doses escalate gradually, and a board-certified allergist oversees the plan — removing the per-visit clinic trip and the 23.9% never-return cliff documented in Tkacz 2021 for eligible patients.
Join the waitlistFrequently asked questions
Is there a standard allergy shot dosage chart?
There isn't a single public dosage chart that applies to everyone, because allergy shot dosing is individualized to your specific allergens, extract concentration, and sensitivity. In general, the build-up phase involves approximately 26-28 weekly injections that step up gradually from a highly diluted starting dose to a maintenance dose set by your allergist. Your allergist's office provides your specific schedule, and any chart you see online is only a general template, not your actual prescription.
Does Curex allergy drops work the same way as allergy shots?
Allergy drops (SLIT) and allergy shots (SCIT) are both forms of allergen immunotherapy and work through the same basic mechanism — gradually exposing the immune system to allergen extract to build tolerance — but they differ in route and dosing. Drops are taken under the tongue at home, while shots are injected subcutaneously in a clinic setting with a mandatory observation period. Which one is more suitable depends on your allergens, sensitivities, and preferences, which an allergist can help you sort out.
Will one allergy shot provide relief?
A single allergy shot will not provide meaningful symptom relief. Build-up is the phase when relief is partial and unreliable. The first injection starts far below the symptom-triggering threshold, so it cannot produce symptom reduction. A single shot is one step in a 26-28-injection build-up protocol designed to reach the maintenance dose, not to provide relief. The cumulative effect accumulates over months and years of consistent dosing, not over a single injection.
How many allergy shots before effectiveness is noticed?
Most patients begin to notice clear improvement between months 6 and 12 of treatment, when the maintenance dose is being established and early maintenance injections have begun. The build-up phase involves approximately 26-28 weekly injections over 6 months. During this phase, relief is partial and unreliable. Maximum symptom and medication reductions typically accrue in years 2-3. If significant improvement is not noticed after 12 months of maintenance, a board-certified allergist should reassess allergen selection and dosing before considering discontinuation.
Does missing an allergy shot reduce effectiveness?
Missing injections can reduce per-injection effectiveness and may require dose reductions at the next visit. Guidelines provide direction for dose adjustment after missed injections — typically requiring a step-down in dose after gaps longer than a certain interval, depending on the gap duration. Dose reduction after a gap adds time to the overall course and reduces per-injection potency in the short term. Consistent adherence is therefore important for maximizing the per-injection biological effect at each visit.
What does each allergy shot do to the immune system?
Each allergy shot delivers a small dose of allergen extract subcutaneously, triggering a local immune response at the injection site. Repeated injections progressively shift the immune response from an allergic pattern toward a regulatory, tolerance-building response. Blocking antibodies compete with the allergy-driving antibody for allergen-binding sites, reducing mast cell and basophil activation. These changes accumulate gradually across hundreds of injections — each shot adds a small increment to the cumulative immunologic shift.
Is effectiveness reduced with multi-allergen vials?
Potentially, yes. US practice commonly uses multi-allergen vials — mixing several allergen extracts into a single injection — while many efficacy trials used single-allergen extracts. Mixing can dilute each component below its effective maintenance dose threshold. It can also cause proteolytic interactions where certain allergens, such as mold and cockroach extracts, degrade other extracts in the vial. A board-certified allergist experienced in SCIT can review whether multi-allergen mixing is appropriate for a given patient's sensitization profile.
How long does each allergy shot visit take?
Each allergy shot visit takes a minimum of 30 minutes for the post-injection observation period, plus the actual injection time and any wait time at the clinic. The 30-minute observation is mandatory — most severe systemic reactions begin within 30 minutes of injection, and the observation period allows the clinic to identify and treat reactions before they progress. In practice, a typical visit runs approximately 45-60 minutes, not counting travel.
Related Articles
Purpose of Allergy Shots: Mechanism & Clinical Intent
Allergy shots induce immune tolerance — IgE to IgG4. Three intents: symptom relief (Cochrane SMD −0.73), less medication, and durable disease modification.
Read moreEffects of Allergy Shots: Intended & Unintended
Allergy shots: real therapeutic effects (Cochrane SMD -0.73) plus ~16% local reactions, 0.1% systemic, and an honest note on the fatigue data gap.
Read moreAllergy Shot For Humans: SCIT & SLIT Guide
Yes, there is an allergy shot for humans — subcutaneous immunotherapy (SCIT). Cochrane SMD −0.73, 3–5 yr course, at home via Curex program quote required. Not Cytopoint.
Read moreTypes of Allergy Shots: Complete Matrix Guide | Curex
8 products called 'allergy shots' compared: SCIT, SLIT tablets, Xolair, Dupixent, Tezspire, depot steroids, epinephrine, and VIT. Only SCIT and SLIT modify allergen immunity.
Read moreEffectiveness of Allergy Shots – Evidence Pyramid | Curex
Effectiveness of allergy shots: Cochrane meta-analyses at apex (SMD −0.73), landmark RCTs in middle, real-world Tkacz 2021 (23.9% never return) at base. Honest synthesis.
Read moreDo Allergy Shots Work? Evidence & Honest Verdict | Curex
Do allergy shots work? Meta-analyses of 51 RCTs show 33-85% symptom reduction — but 20-50% of patients are low responders. Here's the honest evidence.
Read moreGet your allergy shots — without the clinic.
Curex at-home shots require a program quote. Confirm what is included in your plan — a personalized serum compounded to USP <797> sterile standards, board-certified allergist oversight, and one weekly injection you give yourself at home. No clinic visits, no facility fees. HSA/FSA eligible.
Program quote required · Remaining payments for shipped treatment are collected on cancellation
Curex allergy shot serum is compounded at a specialty pharmacy for each patient, and the FDA does not review compounded products for safety or efficacy.
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.
Questions about Curex itself?
Straight answers about the company, the evidence, what patients report, and what it costs — including the parts that are not flattering.